BEAM
Price
$21.03
Change
+$0.28 (+1.35%)
Updated
Jul 21 closing price
Capitalization
2.11B
21 days until earnings call
KURA
Price
$6.47
Change
+$0.11 (+1.73%)
Updated
Jul 21 closing price
Capitalization
560.14M
9 days until earnings call
Interact to see
Advertisement

BEAM vs KURA

Header iconBEAM vs KURA Comparison
Open Charts BEAM vs KURABanner chart's image
Beam Therapeutics
Price$21.03
Change+$0.28 (+1.35%)
Volume$2.93M
Capitalization2.11B
Kura Oncology
Price$6.47
Change+$0.11 (+1.73%)
Volume$1.35M
Capitalization560.14M
BEAM vs KURA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. KURA commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and KURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (BEAM: $21.03 vs. KURA: $6.47)
Brand notoriety: BEAM and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 145% vs. KURA: 104%
Market capitalization -- BEAM: $2.11B vs. KURA: $560.14M
BEAM [@Biotechnology] is valued at $2.11B. KURA’s [@Biotechnology] market capitalization is $560.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while KURA’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • KURA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BEAM and KURA are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -0.66% price change this week, while KURA (@Biotechnology) price change was +1.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +15.66%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

KURA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.12B) has a higher market cap than KURA($560M). BEAM YTD gains are higher at: -15.202 vs. KURA (-25.718). KURA has higher annual earnings (EBITDA): -177.18M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. KURA (658M). KURA has less debt than BEAM: KURA (19.4M) vs BEAM (158M). KURA has higher revenues than BEAM: KURA (68M) vs BEAM (63.6M).
BEAMKURABEAM / KURA
Capitalization2.12B560M378%
EBITDA-399.03M-177.18M225%
Gain YTD-15.202-25.71859%
P/E RatioN/AN/A-
Revenue63.6M68M94%
Total Cash1.22B658M185%
Total Debt158M19.4M814%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKURA
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 30 days ago
85%
Bearish Trend 26 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAYEX23.200.14
+0.61%
Oakmark International Small Cap Advisor
VVOIX22.41N/A
N/A
Invesco Value Opportunities Y
FGIAX12.84N/A
N/A
Nuveen Global Infrastructure A
MDVWX7.83N/A
N/A
Manning & Napier Disciplined Value W
UIVVX12.58N/A
N/A
MFS Intrinsic Value A

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been closely correlated with PYXS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+1.73%
PYXS - KURA
66%
Closely correlated
N/A
ZYME - KURA
44%
Loosely correlated
+0.49%
KYMR - KURA
44%
Loosely correlated
-2.25%
ADVM - KURA
42%
Loosely correlated
-2.17%
BEAM - KURA
42%
Loosely correlated
+1.35%
More